Mannkind (MNKD) Shares Outstanding (Diluted Average) (2020 - 2026)

Mannkind (MNKD) reported Shares Outstanding (Diluted Average) of $308.3 million for Q1 2026, down 3.94% year-over-year from $320.9 million in Q1 2025, and down 1.86% quarter-over-quarter from $314.1 million in Q4 2025.

Mannkind (MNKD) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends

Mannkind (MNKD) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $308.3 million in Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $308.3 million, down 3.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $308.3 million (down 3.94% YoY), and the FY2025 annual result was $314.1 million, up 10.66% from the prior year.
  • Shares Outstanding (Diluted Average) eased to $308.3 million in Q1 2026 per MNKD's latest filing, from $314.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $324.7 million in Q1 2024 and troughed at $251.9 million in Q1 2022.
  • A 5-year average of $287.0 million and a median of $281.4 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) grew 24.86% in 2023, then fell 13.08% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $257.1 million in 2022, then gained by 3.86% to $267.0 million in 2023, then increased by 6.3% to $283.8 million in 2024, then grew by 10.66% to $314.1 million in 2025, then declined by 1.86% to $308.3 million in 2026.
  • Business Quant data shows MNKD's Shares Outstanding (Diluted Average) at $308.3 million in Q1 2026, $314.1 million in Q4 2025, and $313.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn 308.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 308.27 Mn
Dec 31, 2025 314.11 Mn
Sep 30, 2025 313.34 Mn
Jun 30, 2025 312.38 Mn
Mar 31, 2025 320.90 Mn
Dec 31, 2024 283.84 Mn
Sep 30, 2024 281.41 Mn
Jun 30, 2024 279.36 Mn
Mar 31, 2024 324.73 Mn
Dec 31, 2023 267.01 Mn
Sep 30, 2023 323.77 Mn
Jun 30, 2023 264.80 Mn
Mar 31, 2023 263.97 Mn
Dec 31, 2022 257.09 Mn
Sep 30, 2022 259.30 Mn
Jun 30, 2022 253.64 Mn
Mar 31, 2022 251.89 Mn
Dec 31, 2021 249.24 Mn
Sep 30, 2021 248.62 Mn
Jun 30, 2021 247.97 Mn